| Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner AM Schoepfer, E Safroneeva, C Bussmann, T Kuchen, S Portmann, ... Gastroenterology 145 (6), 1230-1236. e2, 2013 | 719 | 2013 |
| Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis I Hirano, ES Dellon, JD Hamilton, MH Collins, K Peterson, M Chehade, ... Gastroenterology 158 (1), 111-122. e10, 2020 | 386 | 2020 |
| Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes AM Schoepfer, C Beglinger, A Straumann, E Safroneeva, Y Romero, ... Inflammatory bowel diseases 19 (2), 332-341, 2013 | 351 | 2013 |
| Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort SR Vavricka, G Rogler, C Gantenbein, M Spoerri, M Prinz Vavricka, ... Inflammatory bowel diseases 21 (8), 1794-1800, 2015 | 291 | 2015 |
| Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis E Safroneeva, A Straumann, M Coslovsky, M Zwahlen, CE Kuehni, ... Gastroenterology 150 (3), 581-590. e4, 2016 | 273 | 2016 |
| Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis AM Schoepfer, A Straumann, R Panczak, M Coslovsky, CE Kuehni, ... Gastroenterology 147 (6), 1255-1266. e21, 2014 | 266 | 2014 |
| Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate AM Schoepfer, MA Dehlavi, N Fournier, E Safroneeva, A Straumann, ... Official journal of the American College of Gastroenterology| ACG 108 (11 …, 2013 | 246 | 2013 |
| RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis I Hirano, MH Collins, Y Assouline-Dayan, L Evans, S Gupta, ... Gastroenterology 156 (3), 592-603. e10, 2019 | 217 | 2019 |
| Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-TNF treatment T Greuter, F Bertoldo, R Rechner, A Straumann, L Biedermann, J Zeitz, ... Journal of pediatric gastroenterology and nutrition 65 (2), 200-206, 2017 | 139 | 2017 |
| Swallowed topical corticosteroids reduce the risk for long‐lasting bolus impactions in eosinophilic esophagitis T Kuchen, A Straumann, E Safroneeva, Y Romero, C Bussmann, ... Allergy 69 (9), 1248-1254, 2014 | 135 | 2014 |
| Colectomy rates in ulcerative colitis are low and decreasing: 10-year follow-up data from the Swiss IBD Cohort Study L Parragi, N Fournier, J Zeitz, M Scharl, T Greuter, P Schreiner, ... Journal of Crohn's and Colitis 12 (7), 811-818, 2018 | 131 | 2018 |
| Eosinophilic oesophagitis and proton pump inhibitor‐responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings FJ Moawad, AM Schoepfer, E Safroneeva, MR Ally, YJ Chen, ... Alimentary pharmacology & therapeutics 39 (6), 603-608, 2014 | 125 | 2014 |
| Long-term treatment of eosinophilic esophagitis with swallowed topical corticosteroids: development and evaluation of a therapeutic concept T Greuter, C Bussmann, E Safroneeva, AM Schoepfer, L Biedermann, ... Official journal of the American College of Gastroenterology| ACG 112 (10 …, 2017 | 120 | 2017 |
| Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease E Safroneeva, SR Vavricka, N Fournier, V Pittet, L Peyrin‐Biroulet, ... Alimentary pharmacology & therapeutics 42 (8), 977-989, 2015 | 110 | 2015 |
| Escalating incidence of eosinophilic esophagitis in C anton of V aud, S witzerland, 1993–2013: a population‐based study B Giriens, P Yan, E Safroneeva, M Zwahlen, A Reinhard, A Nydegger, ... Allergy 70 (12), 1633-1639, 2015 | 108 | 2015 |
| International consensus recommendations for eosinophilic gastrointestinal disease nomenclature ES Dellon, N Gonsalves, JP Abonia, JA Alexander, NC Arva, D Atkins, ... Clinical Gastroenterology and Hepatology 20 (11), 2474-2484. e3, 2022 | 107 | 2022 |
| Anti-TNF treatment for extraintestinal manifestations of inflammatory bowel disease in the Swiss IBD Cohort Study SR Vavricka, M Gubler, C Gantenbein, M Spoerri, F Froehlich, F Seibold, ... Inflammatory bowel diseases 23 (7), 1174-1181, 2017 | 100 | 2017 |
| Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity E Safroneeva, M Coslovsky, CE Kuehni, M Zwahlen, NA Haas, R Panczak, ... Alimentary pharmacology & therapeutics 42 (8), 1000-1010, 2015 | 91 | 2015 |
| Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months P Meyrat, E Safroneeva, AM Schoepfer Alimentary pharmacology & therapeutics 36 (11-12), 1084-1093, 2012 | 91 | 2012 |
| The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma JL Hummel, E Safroneeva, KL Mossman Molecular Therapy 12 (6), 1101-1110, 2005 | 83 | 2005 |
